A concerning update on Dodgers pitcher Brusdar Graterol has left fans and the team alike feeling anxious. Graterol, a key player in the 2024 World Series, has been battling shoulder issues, and his recovery has taken an unexpected turn.
The 27-year-old's journey back from a right shoulder injury has been a challenging one. After undergoing surgery in November 2024, the Dodgers initially expected him to miss the first half of the 2025 season. However, as we approach the new season, Graterol is still not fully ready to take the mound.
The Long Road to Recovery
Graterol's medical history is a complex and controversial topic. His shoulder troubles have been a lingering issue, and his recent progress has been slower than anticipated. Dodgers manager Dave Roberts has confirmed that the team is taking a cautious approach with Graterol, emphasizing the need for a methodical and intentional recovery process.
"Guys are anxious... We've got a long camp ahead, and the message is clear: start slow and focus on the bigger picture."
This cautious strategy is reminiscent of a previous trade situation involving Graterol. In a potential three-team deal with the Boston Red Sox and Minnesota Twins, Graterol's medical history reportedly caused concerns, leading to a reshuffling of the trade terms.
The Spring Training Conundrum
As spring training progresses, Graterol finds himself trailing behind other pitchers in camp, including Blake Snell, Evan Phillips, and Brock Stewart. While Phillips and Stewart's delays are understandable given their recent surgeries, Graterol's situation is more complex. Snell, too, has revealed that he pitched through similar shoulder troubles during the World Series, highlighting the delicate balance between performance and player health.
And this is the part most people miss: the Dodgers' approach to Graterol's recovery isn't just about this season. It's about the long-term health and success of the player and the team. They're erring on the side of caution, prioritizing a full recovery over a rushed return.
But here's where it gets controversial: should the Dodgers push Graterol to get back on track sooner, potentially risking further injury, or continue with their cautious approach, potentially sacrificing short-term gains for long-term gains?
What do you think? Should the Dodgers accelerate Graterol's recovery process, or is their current approach the right one? Let us know your thoughts in the comments!
